Published in Trends Biotechnol on January 18, 2013
Carbapenem and Quinolone Resistance in Klebsiella Pneumoniae | NCT03767283
Escherichia coli in Europe: an overview. Int J Environ Res Public Health (2013) 1.21
The role of microbial biofilms in prosthetic joint infections. Acta Orthop (2014) 0.95
Chemogenomics and orthology-based design of antibiotic combination therapies. Mol Syst Biol (2016) 0.85
Towards the just and sustainable use of antibiotics. J Pharm Policy Pract (2016) 0.85
Synergistic activity and mechanism of action of Stephania suberosa Forman extract and ampicillin combination against ampicillin-resistant Staphylococcus aureus. J Biomed Sci (2014) 0.83
Combination Effects of Antimicrobial Peptides. Antimicrob Agents Chemother (2016) 0.81
Combination therapy with polymyxin B and netropsin against clinical isolates of multidrug-resistant Acinetobacter baumannii. Sci Rep (2016) 0.80
The Complex Relationship between Virulence and Antibiotic Resistance. Genes (Basel) (2017) 0.79
Membrane-Targeting DCAP Analogues with Broad-Spectrum Antibiotic Activity against Pathogenic Bacteria. ACS Med Chem Lett (2015) 0.79
Pilot Screening to Determine Antimicrobial Synergies in a Multidrug-Resistant Bacterial Strain Library. Microb Drug Resist (2016) 0.79
Granulomas and Inflammation: Host-Directed Therapies for Tuberculosis. Front Immunol (2016) 0.79
Live to cheat another day: bacterial dormancy facilitates the social exploitation of β-lactamases. ISME J (2015) 0.78
AcrB-AcrA Fusion Proteins That Act as Multidrug Efflux Transporters. J Bacteriol (2015) 0.78
High Emergence of ESBL-Producing E. coli Cystitis: Time to Get Smarter in Cyprus. Front Microbiol (2016) 0.77
Siderophores in Iron Metabolism: From Mechanism to Therapy Potential. Trends Mol Med (2016) 0.76
In vitro Antibacterial Activity of Combretum edwardsii, Combretum krausii, and Maytenus nemorosa and Their Synergistic Effects in Combination with Antibiotics. Front Pharmacol (2016) 0.75
Pentobra: A Potent Antibiotic with Multiple Layers of Selective Antimicrobial Mechanisms against Propionibacterium Acnes. J Invest Dermatol (2015) 0.75
Novel Potentiators for Vancomycin in the Treatment of Biofilm-Related MRSA Infections via a Mix and Match Approach. ACS Med Chem Lett (2016) 0.75
Property-Guided Synthesis of Aza-Tricyclic Indolines: Development of Gold Catalysis En Route. Adv Synth Catal (2016) 0.75
Construction of antimicrobial peptide-drug combination networks from scientific literature based on a semi-automated curation workflow. Database (Oxford) (2016) 0.75
Antimicrobial synergy between carprofen and doxycycline against methicillin-resistant Staphylococcus pseudintermedius ST71. BMC Vet Res (2016) 0.75
Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria. Emerg Microbes Infect (2016) 0.75
Matrix-assisted laser desorption ionization: time of flight mass spectrometry-identified models for detection of ESBL-producing bacterial strains. Med Sci Monit Basic Res (2014) 0.75
Metabolic fingerprinting of bacteria by fluorescence lifetime imaging microscopy. Sci Rep (2017) 0.75
2-aminoimidazoles potentiate ß-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ß-lactamase secretion and increasing cell envelope permeability. PLoS One (2017) 0.75
The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis (2008) 9.57
Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis (2007) 6.75
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect (2006) 6.40
Molecular mechanisms that confer antibacterial drug resistance. Nature (2000) 5.88
New uses for old drugs. Nature (2007) 5.86
Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother (2001) 5.23
Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg (2007) 4.58
Where will new antibiotics come from? Nat Rev Microbiol (2003) 3.99
HIV chemotherapy. Nature (2001) 3.63
High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe. Antimicrob Agents Chemother (2006) 3.38
Does broad-spectrum beta-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? J Antimicrob Chemother (2011) 3.01
Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob Agents Chemother (2009) 2.96
Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor. Proc Natl Acad Sci U S A (2012) 2.27
Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use. Biochem Pharmacol (2006) 2.14
Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. Antimicrob Agents Chemother (2011) 2.09
Role of VraSR in antibiotic resistance and antibiotic-induced stress response in Staphylococcus aureus. Antimicrob Agents Chemother (2006) 1.94
Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy. Nat Chem Biol (2011) 1.84
Combination therapy for treatment of infections with gram-negative bacteria. Clin Microbiol Rev (2012) 1.84
Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies. Clin Microbiol Infect (2008) 1.82
Two-component signal transduction as potential drug targets in pathogenic bacteria. Curr Opin Microbiol (2010) 1.74
Synergistic effects between conventional antibiotics and 2-aminoimidazole-derived antibiofilm agents. Antimicrob Agents Chemother (2010) 1.64
Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan biosyntheses in Staphylococcus aureus. ACS Chem Biol (2010) 1.64
The chemotherapy of tuberculosis: past, present and future. Int J Tuberc Lung Dis (2012) 1.61
Antibacterial agents that inhibit two-component signal transduction systems. Proc Natl Acad Sci U S A (1998) 1.53
Microbiology. Desperately seeking new antibiotics. Science (2008) 1.51
Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria. Biochim Biophys Acta (2008) 1.40
Targeting a bacterial stress response to enhance antibiotic action. Proc Natl Acad Sci U S A (2009) 1.39
Combination therapies for combating antimicrobial resistance. Curr Opin Microbiol (2011) 1.37
Suppression of beta-lactam antibiotic resistance in a methicillin-resistant Staphylococcus aureus through synergic action of early cell wall inhibitors and some other antibiotics. J Antimicrob Chemother (1997) 1.35
Histidine kinases as targets for new antimicrobial agents. Bioorg Med Chem (2002) 1.33
Inhibition of WTA synthesis blocks the cooperative action of PBPs and sensitizes MRSA to β-lactams. ACS Chem Biol (2012) 1.29
Enhancement of antibiotic activity against poly-drug resistant Mycobacterium tuberculosis by phenothiazines. Int J Antimicrob Agents (2001) 1.26
Sequencing of superbugs seen as key to combating their spread. Nat Med (2010) 1.17
Potent small-molecule suppression of oxacillin resistance in methicillin-resistant Staphylococcus aureus. Angew Chem Int Ed Engl (2012) 1.14
Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: potential use for initial therapy of freshly diagnosed tuberculosis. J Antimicrob Chemother (1996) 1.06
Small molecule suppression of carbapenem resistance in NDM-1 producing Klebsiella pneumoniae. ACS Med Chem Lett (2012) 1.04
Evaluation of 4,5-disubstituted-2-aminoimidazole-triazole conjugates for antibiofilm/antibiotic resensitization activity against MRSA and Acinetobacter baumannii. ChemMedChem (2011) 1.01
Improved oxacillin treatment outcomes in experimental skin and lung infection by a methicillin-resistant Staphylococcus aureus isolate with a vraSR operon deletion. Antimicrob Agents Chemother (2011) 1.01
Designer combination therapy for cancer. Nat Biotechnol (2006) 1.00
A forward chemical screen identifies antibiotic adjuvants in Escherichia coli. ACS Chem Biol (2012) 0.99
The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosis. PLoS One (2010) 0.99
Where are all the new antibiotics? The new antibiotic paradox. Can J Infect Dis Med Microbiol (2005) 0.98
Reversal of methicillin resistance in Staphylococcus aureus by thioridazine. J Antimicrob Chemother (2008) 0.98
New treatment options against gram-negative organisms. Crit Care (2011) 0.98
Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now! Int J Antimicrob Agents (2010) 0.97
Role of the two component signal transduction system CpxAR in conferring cefepime and chloramphenicol resistance in Klebsiella pneumoniae NTUH-K2044. PLoS One (2012) 0.94
In vitro and in vivo properties of BAL30376, a β-lactam and dual beta-lactamase inhibitor combination with enhanced activity against Gram-negative Bacilli that express multiple β-lactamases. Antimicrob Agents Chemother (2011) 0.92
Comparative in vitro activity of phenothiazines against multidrug-resistant Mycobacterium tuberculosis. Int J Antimicrob Agents (2000) 0.92
Thioridazine potentiates the effect of a beta-lactam antibiotic against Staphylococcus aureus independently of mecA expression. Res Microbiol (2012) 0.91
Thioridazine affects transcription of genes involved in cell wall biosynthesis in methicillin-resistant Staphylococcus aureus. FEMS Microbiol Lett (2011) 0.91
Reversal of resistance in microorganisms by help of non-antibiotics. J Antimicrob Chemother (2007) 0.90
Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections. Int J Antimicrob Agents (2012) 0.89
The anti-inflammatory non-antibiotic helper compound diclofenac: an antibacterial drug target. Eur J Clin Microbiol Infect Dis (2009) 0.88
In vitro activity of LK-157, a novel tricyclic carbapenem as broad-spectrum {beta}-lactamase inhibitor. Antimicrob Agents Chemother (2008) 0.88
Societal costs versus savings from wild-card patent extension legislation to spur critically needed antibiotic development. Infection (2007) 0.86
Inhibition of bacterial multidrug resistance by celecoxib, a cyclooxygenase-2 inhibitor. Antimicrob Agents Chemother (2010) 0.86
N-substituted 2-aminoimidazole inhibitors of MRSA biofilm formation accessed through direct 1,3-bis(tert-butoxycarbonyl)guanidine cyclization. Org Biomol Chem (2013) 0.85
The clinical development and launch of amoxicillin/clavulanate for the treatment of a range of community-acquired infections. Int J Antimicrob Agents (2007) 0.85
Pyrazolo[4,3-c][1,2]benzothiazines 5,5-dioxide: a promising new class of Staphylococcus aureus NorA efflux pump inhibitors. J Med Chem (2012) 0.82
Efficacy of piperacillin combined with the Penem beta-lactamase inhibitor BLI-489 in murine models of systemic infection. Antimicrob Agents Chemother (2009) 0.80
Promethazine renders Escherichia coli susceptible to penicillin G: real-time measurement of bacterial susceptibility by fluoro-luminometry. Int J Antimicrob Agents (2007) 0.80
Arresting cancer proliferation by small-molecule gene regulation. Chem Biol (2004) 1.90
Inhibition of HIV fusion with multivalent gold nanoparticles. J Am Chem Soc (2008) 1.84
Accessibility of nuclear chromatin by DNA binding polyamides. Chem Biol (2003) 1.81
DNA sequence-specific polyamides alleviate transcription inhibition associated with long GAA.TTC repeats in Friedreich's ataxia. Proc Natl Acad Sci U S A (2006) 1.70
Synergistic effects between conventional antibiotics and 2-aminoimidazole-derived antibiofilm agents. Antimicrob Agents Chemother (2010) 1.64
Polyamides reveal a role for repression in latency within resting T cells of HIV-infected donors. J Infect Dis (2004) 1.64
Crystal structures of nucleosome core particles in complex with minor groove DNA-binding ligands. J Mol Biol (2003) 1.63
Small molecule control of bacterial biofilms. Org Biomol Chem (2012) 1.51
Targeted derepression of the human immunodeficiency virus type 1 long terminal repeat by pyrrole-imidazole polyamides. J Virol (2002) 1.24
Controlling bacterial biofilms. Chembiochem (2009) 1.24
Synthesis and screening of an oroidin library against Pseudomonas aeruginosa biofilms. Chembiochem (2008) 1.15
Potent small-molecule suppression of oxacillin resistance in methicillin-resistant Staphylococcus aureus. Angew Chem Int Ed Engl (2012) 1.14
Inhibition of Pseudomonas aeruginosa biofilm formation with Bromoageliferin analogues. J Am Chem Soc (2007) 1.13
Sequence specific fluorescence detection of double strand DNA. J Am Chem Soc (2003) 1.11
A 2-aminobenzimidazole that inhibits and disperses gram-positive biofilms through a zinc-dependent mechanism. J Am Chem Soc (2009) 1.11
Blocking transcription through a nucleosome with synthetic DNA ligands. J Mol Biol (2002) 1.11
Inhibition and dispersion of Pseudomonas aeruginosa biofilms with reverse amide 2-aminoimidazole oroidin analogues. Org Biomol Chem (2008) 1.10
Synthesis and antibiofilm activity of a second-generation reverse-amide oroidin library: a structure-activity relationship study. Chemistry (2008) 1.09
Construction and screening of a 2-aminoimidazole library identifies a small molecule capable of inhibiting and dispersing bacterial biofilms across order, class, and phylum. Angew Chem Int Ed Engl (2008) 1.09
A new small molecule specifically inhibits the cariogenic bacterium Streptococcus mutans in multispecies biofilms. Antimicrob Agents Chemother (2011) 1.08
Small molecule suppression of carbapenem resistance in NDM-1 producing Klebsiella pneumoniae. ACS Med Chem Lett (2012) 1.04
Modulating the development of E. coli biofilms with 2-aminoimidazoles. Bioorg Med Chem Lett (2010) 1.02
Evaluation of 4,5-disubstituted-2-aminoimidazole-triazole conjugates for antibiofilm/antibiotic resensitization activity against MRSA and Acinetobacter baumannii. ChemMedChem (2011) 1.01
Amide isosteres of oroidin: assessment of antibiofilm activity and C. elegans toxicity. J Med Chem (2009) 1.01
Synthesis and bacterial biofilm inhibition studies of ethyl N-(2-phenethyl) carbamate derivatives. Org Biomol Chem (2010) 0.99
Control of bacterial biofilms with marine alkaloid derivatives. Mol Biosyst (2008) 0.97
Inhibition and dispersion of proteobacterial biofilms. Chem Commun (Camb) (2008) 0.97
A flexible approach to 1,4-di-substituted 2-aminoimidazoles that inhibit and disperse biofilms and potentiate the effects of β-lactams against multi-drug resistant bacteria. Eur J Med Chem (2012) 0.97
The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii. Bioorg Med Chem (2009) 0.96
Promoter scanning for transcription inhibition with DNA-binding polyamides. Mol Cell Biol (2002) 0.96
Effects of N-pyrrole substitution on the anti-biofilm activities of oroidin derivatives against Acinetobacter baumannii. Bioorg Med Chem Lett (2008) 0.95
Antibiofilm activity of a diverse oroidin library generated through reductive acylation. J Org Chem (2009) 0.95
Identification of BfmR, a response regulator involved in biofilm development, as a target for a 2-Aminoimidazole-based antibiofilm agent. Biochemistry (2012) 0.93
Growth inhibition of Staphylococcus aureus by mixed monolayer gold nanoparticles. Small (2011) 0.91
Identification of antibiotics using small molecule variable ligand display on gold nanoparticles. Chem Commun (Camb) (2010) 0.91
Small molecule downregulation of PmrAB reverses lipid A modification and breaks colistin resistance. ACS Chem Biol (2013) 0.91
Structural studies on 4,5-disubstituted 2-aminoimidazole-based biofilm modulators that suppress bacterial resistance to β-lactams. ChemMedChem (2012) 0.91
Inhibition of DNA binding by human estrogen-related receptor 2 and estrogen receptor alpha with minor groove binding polyamides. Biochemistry (2005) 0.91
Inhibition of Acinetobacter baumannii, Staphylococcus aureus and Pseudomonas aeruginosa biofilm formation with a class of TAGE-triazole conjugates. Org Biomol Chem (2009) 0.91
Overcoming resistance to β-lactam antibiotics. J Org Chem (2013) 0.90
Mimicking the biological activity of diazobenzo[b]fluorene natural products with electronically tuned diazofluorene analogs. Bioorg Med Chem Lett (2006) 0.90
Chemical synthesis and biological screening of 2-aminoimidazole-based bacterial and fungal antibiofilm agents. Chembiochem (2010) 0.89
Programmable DNA-binding small molecules. Bioorg Med Chem (2013) 0.89
Synthesis and biological activity of 2-aminoimidazole triazoles accessed by Suzuki-Miyaura cross-coupling. Org Biomol Chem (2011) 0.89
Expression of antimicrobial drug tolerance by attached communities of Mycobacterium tuberculosis. Pathog Dis (2014) 0.88
Small-molecule inhibition of bacterial two-component systems to combat antibiotic resistance and virulence. Future Med Chem (2013) 0.88
Nanoscale structure-activity relationships, mode of action, and biocompatibility of gold nanoparticle antibiotics. J Am Chem Soc (2014) 0.88
Intercepting bacterial indole signaling with flustramine derivatives. J Am Chem Soc (2011) 0.88
Flustramine inspired synthesis and biological evaluation of pyrroloindoline triazole amides as novel inhibitors of bacterial biofilms. Org Biomol Chem (2011) 0.88
Identification of aryl 2-aminoimidazoles as biofilm inhibitors in Gram-negative bacteria. Bioorg Med Chem Lett (2010) 0.87
Synthesis and biological evaluation of 2-aminoimidazole/carbamate hybrid anti-biofilm and anti-microbial agents. Bioorg Med Chem Lett (2010) 0.87
Biologically inspired strategies for combating bacterial biofilms. Curr Opin Pharmacol (2013) 0.86
Small-molecule suppression of β-lactam resistance in multidrug-resistant gram-negative pathogens. J Med Chem (2014) 0.85
N-substituted 2-aminoimidazole inhibitors of MRSA biofilm formation accessed through direct 1,3-bis(tert-butoxycarbonyl)guanidine cyclization. Org Biomol Chem (2013) 0.85
Anti-biofilm compounds derived from marine sponges. Mar Drugs (2011) 0.84
A facile synthesis of 1,5-disubstituted-2-aminoimidazoles: antibiotic activity of a first generation library. Bioorg Med Chem Lett (2011) 0.84
Synthesis of a 2-aminoimidazole library for antibiofilm screening utilizing the Sonogashira reaction. J Org Chem (2008) 0.84
Inhibition of Acinetobacter baumannii biofilm formation on a methacrylate polymer containing a 2-aminoimidazole subunit. Chem Commun (Camb) (2011) 0.83
¹H, ¹³C, and ¹⁵N resonance assignments and secondary structure prediction of the full-length transition state regulator AbrB from Bacillus anthracis. Biomol NMR Assign (2011) 0.81
Indole/triazole conjugates are selective inhibitors and inducers of bacterial biofilms. Medchemcomm (2013) 0.81
Tandem dispersion and killing of bacteria from a biofilm. Org Biomol Chem (2008) 0.81
Reversal of Mycobacterium tuberculosis phenotypic drug resistance by 2-aminoimidazole-based small molecules. Pathog Dis (2014) 0.81
Evaluation of the toxicity of 2-aminoimidazole antibiofilm agents using both cellular and model organism systems. Drug Chem Toxicol (2012) 0.81
Highly active modulators of indole signaling alter pathogenic behaviors in Gram-negative and Gram-positive bacteria. Chemistry (2013) 0.80
A nitroenolate approach to the synthesis of 4,5-disubstituted-2-aminoimidazoles. Pilot library assembly and screening for antibiotic and antibiofilm activity. Org Biomol Chem (2010) 0.80
Targeting RNA with cysteine-constrained peptides. Bioorg Med Chem Lett (2007) 0.78
Membrane-permeabilizing activity of reverse-amide 2-aminoimidazole antibiofilm agents against Acinetobacter baumannii. Curr Drug Deliv (2015) 0.77
Deconvoluting interspecies bacterial communication. Angew Chem Int Ed Engl (2012) 0.77
2-Aminopyrimidine as a novel scaffold for biofilm modulation. Org Biomol Chem (2012) 0.77
Innovative strategies for combating biofilm-based infections. Adv Exp Med Biol (2015) 0.76
The discovery of N-1 substituted 2-aminobenzimidazoles as zinc-dependent S. aureus biofilm inhibitors. Medchemcomm (2012) 0.76
Medicinal chemistry: Forcing an enemy into the open. Nat Chem (2012) 0.75
Chemical shift assignments and secondary structure prediction of the C-terminal domain of the response regulator BfmR from Acinetobacter baumannii. Biomol NMR Assign (2012) 0.75
Thiol-modified gold nanoparticles for the inhibition of Mycobacterium smegmatis. Chem Commun (Camb) (2014) 0.75
Screening an established natural product library identifies secondary metabolites that potentiate conventional antibiotics. ACS Infect Dis (2020) 0.75